
Stay informed on the latest in arthritis prevention, research, treatment and care with JointHealth™ express, Canada's trusted source for arthritis news. Delivered right to your inbox, this "breaking news" bulletin provides timely updates on key arthritis topics, including disease management, research breakthroughs, and treatment advancements. As the longest-running arthritis news source in Canada, JointHealth™ express provides you expert insights from patients and analysis from arthritis health care professionals to help you on your arthritis journey. Stay connected to the arthritis information that matters most.
Click here to see JointHealth™ express bulletins from 2023 and earlier.
Latest News
Arthritis At Home 297 – Cost of juvenile arthritis to patients and families
Call for patient input on roflumilast (Zoryve®) for plaque psoriasis
Canada’s Drug Agency (CDA-AMC) is currently welcoming patients and their caregivers to provide input to patient organizations on the manufacturer’s ...
Arthritis At Home 296 – Sports medicine in juvenile idiopathic arthritis and artificial intelligence scribing
Let BC PharmaCare hear Your Voice on upadacitinib (Rinvoq®) for the treatment of giant cell arteritis
Upadacitinib (Rinvoq®) is now being considered for coverage under the British Columbia Ministry of Health’s PharmaCare program. By filling out ...
Let BC PharmaCare hear Your Voice on roflumilast cream (Zoryve®) for the treatment of atopic dermatitis in patients 6 years of age and older
Roflumilast cream (Zoryve®) is now being considered for coverage under the British Columbia Ministry of Health’s PharmaCare program. By filling ...
Arthritis At Home 295 – 2025 ACE Report Card on Arthritis Medication Coverage
New blog post from Joint Journeys, life with arthritis by Carrie: Wander lust
Living with Lupus? We want to hear from you!
Arthritis At Home – Living with Lupus? We want to hear from you!
The 10th Annual Patients Redefining the Future of Health Care in Canada Summit is happening November 25-27, 2025
Invitation to Digestive Cancers Europe’s “Patents: Empowering advocates through knowledge” webinar on November 6, 2025